Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2016 - Google Patents
(57) ABSTRACT A pharmaceutical composition comprising an active agent that causes
reduction of the level of systemic immunosup pression in an individual for use intreating a …

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2019 - Google Patents
The present specification discloses a pharmaceutical composition comprising an active
agent that causes reduction of the level of systemic immunosuppression in an individual for …

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2019 - Google Patents
(57) ABSTRACT A pharmaceutical composition comprising an active agent that causes
reduction of the level of systemic immunosup pression in an individual for use in treating a …

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2016 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …

PD-1 binding proteins and methods of use thereof

B Bennett, PP Chamberlain, K Hariharan… - US Patent …, 2019 - Google Patents
US10428145B2 - PD-1 binding proteins and methods of use thereof - Google Patents
US10428145B2 - PD-1 binding proteins and methods of use thereof - Google Patents PD-1 …

Methods of conditioning patients for T cell therapy

A Bot, JS Wiezorek, GO William, J Rajul… - US Patent …, 2018 - Google Patents
The invention provides methods of increasing the efficacy of a T cell therapy in a patient in
need thereof. The invention includes a method of conditioning a patient prior to a T cell …

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2016 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2017 - Google Patents
2016-07-28 Assigned to YEDA RESEARCH AND DEVELOPMENT CO., LTD. reassignment
YEDA RESEARCH AND DEVELOPMENT CO., LTD. ASSIGNMENT OF ASSIGNORS …